A sensitive and reliable ultra-high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of ibuprofen in plasma to investigate the pharmacokinetics of ibuprofen after oral administration of ibuprofen sustained-release capsules.
Abstract
Ibuprofen is a nonsteroidal anti-inflammatory drug first launched in England in 1969, yet its pharmacokinetic profile in healthy Chinese volunteers remains insufficiently characterized. In this study, a sensitive and reliable ultra-high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of ibuprofen in plasma. Plasma samples were pretreated via one-step protein precipitation with diclofenac sodium as the internal standard (IS). Chromatographic separation was carried out on a Hedera ODS-2 column with gradient elution utilizing methanol and 5 mM ammonium acetate buffer containing 0.2% acetic acid at a flow rate of 0.35 mL min
−1
. LC-MS/MS equipped with an electrospray ionization (ESI) source was used in negative ion mode and multiple-reaction monitoring (MRM) mode with transitions monitored at
m/z
205.1→161.1 for ibuprofen and
m/z
294.1→250.1 for IS, respectively. Standard curve for ibuprofen was linear from 0.015 to 30 μg mL
−1
, illustrating a lower limit of quantitation (LLOQ) than previously reported methods. The intra- and inter-day precision for ibuprofen was below 12.0%, with accuracies within ±7.5%. Extraction recoveries ranged from 84.8 to 91.1%, and matrix effects were between 92.4 and 95.2%. Ibuprofen demonstrated satisfactory stability under various storage conditions. This method was then successfully executed to investigate the pharmacokinetics of ibuprofen after oral administration of ibuprofen sustained-release capsules. Furthermore, the gender effect on the pharmacokinetics of ibuprofen was also evaluated.
A sensitive, rapid, and robust liquid chromatography-tandem mass spectrometry method incorporating a stable isotope-labeled internal standard incorporating phloroglucinol-13C6 was developed and validated and successfully applied to a pharmacokinetic and bioequivalence study of phloroglucinol orally disintegrating table...
Qi-Qin Sun, Xiang-Hong Li, Yun-Jie Dong et al.· Journal of chromatography. B...· 0 citations
The developed UHPLC-MS/MS method was successfully applied in a bioequivalence study involving 33 healthy volunteers following oral administration of a single 5 mL dose of Flucamox® 250 mg, enabling comprehensive pharmacokinetic evaluation while promoting sustainable and resource-efficient analytical practices.
M. Hegazy, Ashraf S. Ibrahim, M. Kenawy et al.· Analytical and Bioanalytical...· 0 citations
The clinical development of a sustained-release amlexanox formulation with reduced dosing frequency and improved patient compliance is supported and support the clinical development of a sustained-release amlexanox formulation with reduced dosing frequency and improved patient compliance.
A sensitive, reliable, and rapid UPLC–MS/MS method was developed and validated for the simultaneous determination of ensartinib and M465 in rat plasma and applied to a rat pharmacokinetic study and provides useful analytical support for further preclinical investigations of ensartinib and its major metabolite.
Shi-Qi Jiang, Yan Chen, Lu Cao et al.· Drug Design, Development and...· 0 citations
The findings regarding accuracy, specificity, sensitivity, matrix effect, recovery and stability findings of Lurbinectedin in plasma samples for the established method highlight its significance in bioequivalence and pharmacokinetic studies.
P. Sankar, Naresh Panigrahi· International Journal of App...· 0 citations
The developed LC-MS/MS method for quantifying repotrectinib in rat plasma exhibited reliability and suitability for pharmacokinetic evaluation, as evidenced by a Cmax of 52.30±0.79 ng/ml at Tmax of 5 h in rats.
Sathish Sabbani, G. Chakravarthi, Narender Malothu· International Journal of App...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.